Journey Medical Corporation — Quarterly Financial Statistics (NASDAQ:DERM) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Cash from operating activities 1.16 M-2.23 M2.83 M942 K2.38 M 3.93 M Cash from investing activities -26 K-25 K-17 K-26 K-26 K -94 K Cash from financing activities -294 K10.62 M3.6 M165 K7.04 M 21.42 M Free cash flow 1.16 M-2.23 M2.83 M942 K2.38 M 3.93 M

Notícias

B.Riley bestätigt "Buy"-Rating für Journey Medical und Kursziel von 12 US-Dollar

B.Riley reiterates Buy rating on Journey Medical stock, maintains $12 target

Journey Medical Stock: Emrosi Is Winning, But The Stock Hasn't Noticed (NASDAQ:DERM)

FDA setzt neuen PDUFA-Termin für Menkes-Therapie von Fortress Biotech fest

Journey Medical: Studie belegt Verträglichkeit von Rosazea-Mittel Emrosi für das Mikrobiom

Minocycline study shows no microbiome disruption after 16-week use

Journey Medical: EPS verfehlt Schätzungen um 0,06 $ - Umsatz schlechter als erwartet

Journey Medical earnings missed by $0.06, revenue fell short of estimates

Compared to Estimates, Journey Medical (DERM) Q3 Earnings: A Look at Key Metrics

Earnings Call: Journey Medical meldet Umsatzwachstum für Q3 2025 und stellt positives EBITDA in Aussicht

Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates

Cisco, Flutter, Manulife and more set to report earnings Wednesday